ARKGvsPBEETF Comparison
VS
ARK Genomic Revolution ETF (ARKG) and Invesco Dynamic Biotechnology & Genome ETF (PBE) belong to the same industry segment: BioTech & Genomics. ARKG's top 3 sector exposures are Health Care and Information Technology. In contrast, PBE's top sector exposures are Health Care ARKG is more expensive with a Total Expense Ratio (TER) of 0.75%, versus 0.58% for PBE. ARKG is down -2.36% year-to-date (YTD) with -$17M in YTD flows. PBE performs worse with -2.86% YTD performance, and -$5M in YTD flows. Run a side-by-side ETF comparison of ARKG and PBE below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
ARKG vs PBE performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 04/29/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | ARKG PBE | +14.98%+0.19% | -9.13%-3.62% | -2.36%-2.86% | +27.92%+30.75% | -2.43%+27.35% | -67.96%+8.21% |
| Flows | ARKG PBE | -$2M-$783K | -$53M-$9M | -$17M-$5M | -$66M-$31M | -$583M-$61M | -$3.03B-$46M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | ARKG PBE | +43.08%+19.66% | +41.66%+19.86% | +42.62%+20.11% | +45.37%+22.54% |
| Max drawdown | ARKG PBE | -20.97%-9.36% | -27.52%-11.70% | -51.98%-22.21% | -80.16%-34.74% |
| Max drawdown duration | ARKG PBE | 90d82d | 97d114d | 1015d324d | 1765d1540d |
Trading data
ARKG | PBE | |
Last sale 5/1/2026 at 1:30 PM | $30.30 | $79.69 |
| Previous close 04/29/2026 | $29.87 | $79.58 |
| Consolidated volume 04/29/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of April 30, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
ARKG
is actively managed and doesn’t replicate an indexARKG | PBE | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 5/1/2026 at 1:30 PM
Live
Closed
ARKG | PBE | |
|---|---|---|
| Last price | $30.30 | $79.69 |
| 1D performance | +1.44% | +0.14% |
| AuM | $1.13 B | $246.16 M |
| E/R | 0.75% | 0.58% |
Characteristics
ARKG | PBE | |
|---|---|---|
| Management strategy | Active | Passive |
| Provider | Ark Investment | Invesco |
| Benchmark | - | Dynamic Biotech & Genome Intellidex Index |
| N° of holdings | 27 | 30 |
| Asset class | - | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | April 2, 2019 | June 23, 2005 |
| ESG | No | No |
Advertisement
Exposure
Countries
ARKG
USA
70.4%
Switzerland
9.23%
Other
20.37%
PBE
USA
92.18%
Other
7.82%
Sectors
ARKG
Health Care
78.38%
Other
21.62%
PBE
Health Care
97.59%
Other
2.41%
Advertisement
Diversification
ARKG
Total weight of top 15 holdings out of 15
62.5%
PBE
Total weight of top 15 holdings out of 15
63.66%
Top 15 holdings
Data as of March 31, 2026
ARKG
CRISPR THERAPEUTICS
9.23%
10X GENOMICS INC
6.30%
BEAM THERAPEUTICS
4.86%
PERSONALIS INC
4.69%
NATERA
4.48%
ILLUMINA
4.45%
GUARDANT HEALTH INC
4.21%
INTELLIA THERAPEUTICS INC
3.58%
CAREDX INC/D
3.56%
RECURSION PHARMACEUTICALS
3.54%
ABSCI
3.27%
VERACYTE INC/D
2.98%
ADAPTIVE BIOTECHNOLOGIES
2.71%
NURIX THERAPEUTICS
2.45%
SEMA4 HOLDINGS CORP
2.19%
PBE
UTD THERAPEUT
6.05%
ILLUMINA
5.24%
REGENERON PHARMACEUTICALS
5.23%
ALNYLAM PHARMACEUTICALS
5.22%
BIOGEN INC
5.16%
AMGEN-T
4.99%
GILEAD SCIENCES
4.98%
INCYTE
4.89%
BIOCRYST PHARMACEUTICALS
3.66%
PROTAGONIST THERAPEUTICS INC
3.38%
TG THERAPEUTICS
3.11%
ROYALTY PHARMA
3.05%
NEUROCRINE BIOSCIENCES
2.93%
CATALYST PHARMACEUTICALS INC
2.89%
PTC THERAPEUTI/D
2.86%
Frequently asked questions about ARKG and PBE
How have the ARKG and PBE ETFs performed in 2026?
As of April 29, 2026, ARKG is down -2.36% year-to-date (YTD), while PBE has lost -2.86%. That puts ARKG better performer ahead so far this year.
Which ETF is attracting more investor money: ARKG or PBE?
Year-to-date, the ARKG ETF saw -$17M in flows, compared to -$5M for PBE.
Which ETF is more volatile: ARKG or PBE?
Over the past year, ARKG had a volatility of 41.66%, while PBE experienced 19.86%.
Which ETF is bigger: ARKG or PBE?
As of April 29, 2026, ARKG holds $1.13 B in assets under management (AUM), while PBE manages $246.16 M.
What sectors do the ARKG and PBE ETFs invest in?
ARKG leans toward sectors like Health Care. Meanwhile, PBE focuses on Health Care.
What are the top holdings of the ARKG ETF and PBE ETF?
ARKG top holdings include CRISPR THERAPEUTICS, 10X GENOMICS INC and BEAM THERAPEUTICS. PBE holds in its top three: UTD THERAPEUT, ILLUMINA and REGENERON PHARMACEUTICALS.
Which ETF is more diversified: ARKG or PBE?
ARKG holds 27 securities with 62.5% of its assets in the top 15. PBE has 30 securities and a top 15 weight of 63.66%.
Advertisement
Latest news about ARKG & PBE
Advertisement
